A client with a diagnosis of AIDS is taking a combination of a protease inhibitor, a non-nucleoside reverse transcriptase inhibitor, and 2 nucleoside reverse transcriptase inhibitors. What is the rationale for using a multi-drug treatment regimen in this client?